---
title: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes
date: '2024-11-18'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39555827/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20241118172045&v=2.18.0.post9+e462414
source: N Engl J Med
description: 'CONCLUSIONS: Among patients with type 2 diabetes, the incidence of major
  cardiovascular events was significantly lower with intensive treatment targeting
  a systolic blood pressure of less than 120 mm Hg than with standard treatment targeting
  a systolic blood pressure of less than 140 mm Hg. (Funded by the National Key Research
  and Development Program of the Ministry of Science and Technology of China and others;
  BPROAD ClinicalTrials.gov number, ...'
disable_comments: true
---
CONCLUSIONS: Among patients with type 2 diabetes, the incidence of major cardiovascular events was significantly lower with intensive treatment targeting a systolic blood pressure of less than 120 mm Hg than with standard treatment targeting a systolic blood pressure of less than 140 mm Hg. (Funded by the National Key Research and Development Program of the Ministry of Science and Technology of China and others; BPROAD ClinicalTrials.gov number, ...